有前景-话题@MedSci

#有前景#

15篇内容 | 594人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2080921, encodeId=ce942080921ad, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=ESMO 2022：Sacituzumab Govitecan-hziy在HER2-低表达/HER2-0转移性乳腺癌中显示出有前景的疗效（TROPiCS-02研究）, objectType=article, longId=739076, objectId=83fde390764d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83fde390764d, replyNumber=0, likeNumber=31, createdTime=2023-05-23, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83fde390764d, moduleTitle=ESMO 2022：Sacituzumab Govitecan-hziy在HER2-低表达/HER2-0转移性乳腺癌中显示出有前景的疗效（TROPiCS-02研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83fde390764d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080920, encodeId=dffa2080920af, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=BMC Cancer：白蛋白紫杉醇联合PD-1抑制剂信迪利单抗是晚期软组织肉瘤(STS)的有前景治疗方案, objectType=article, longId=294052, objectId=a3fb294052fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3fb294052fd, replyNumber=0, likeNumber=48, createdTime=2022-12-08, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3fb294052fd, moduleTitle=BMC Cancer：白蛋白紫杉醇联合PD-1抑制剂信迪利单抗是晚期软组织肉瘤(STS)的有前景治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3fb294052fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080919, encodeId=fcb020809194e, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=Stroke：中性粒细胞计数作为预测动脉瘤性蛛网膜下腔出血患者住院死亡率有前景的标志物, objectType=article, longId=213400, objectId=d7af213400da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7af213400da, replyNumber=0, likeNumber=30, createdTime=2021-10-22, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7af213400da, moduleTitle=Stroke：中性粒细胞计数作为预测动脉瘤性蛛网膜下腔出血患者住院死亡率有前景的标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7af213400da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080918, encodeId=f3d02080918ad, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=Medicine：乌司他丁联合中药大黄可能是改善败血症的一种有前景的治疗方案, objectType=article, longId=207769, objectId=9acb20e769a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9acb20e769a1, replyNumber=0, likeNumber=35, createdTime=2022-01-21, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9acb20e769a1, moduleTitle=Medicine：乌司他丁联合中药大黄可能是改善败血症的一种有前景的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9acb20e769a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080917, encodeId=4262208091e6d, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=Clinica Chimica Acta：血清脂蛋白相关磷脂酶A2是一种有前景预后生物标志物，与急性脑出血90天的预后有关, objectType=article, longId=179880, objectId=9c931e9880bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c931e9880bd, replyNumber=0, likeNumber=41, createdTime=2020-02-01, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c931e9880bd, moduleTitle=Clinica Chimica Acta：血清脂蛋白相关磷脂酶A2是一种有前景预后生物标志物，与急性脑出血90天的预后有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c931e9880bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080916, encodeId=ef7a20809162e, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=石榴中的抗衰老化合物在人类临床试验中被证明有前景, objectType=article, longId=168774, objectId=701c168e74d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=701c168e74d6, replyNumber=0, likeNumber=37, createdTime=2019-10-22, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=701c168e74d6, moduleTitle=石榴中的抗衰老化合物在人类临床试验中被证明有前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=701c168e74d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080914, encodeId=0a52208091480, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=Sci Rep：一个很有前景的前列腺癌预测工具PI-RADS V2介绍, objectType=article, longId=166430, objectId=0e9716643009, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9716643009, replyNumber=0, likeNumber=38, createdTime=2019-09-28, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9716643009, moduleTitle=Sci Rep：一个很有前景的前列腺癌预测工具PI-RADS V2介绍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e9716643009)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080915, encodeId=3f8a20809156f, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=BMS的PD-1单抗联合CTLA-4单抗治疗肝细胞癌的早期临床结果很有前景, objectType=article, longId=167676, objectId=769c16e676a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=769c16e676a7, replyNumber=0, likeNumber=33, createdTime=2020-04-27, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=769c16e676a7, moduleTitle=BMS的PD-1单抗联合CTLA-4单抗治疗肝细胞癌的早期临床结果很有前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=769c16e676a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080911, encodeId=0714208091197, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=ACS Appl Mater Interfaces：超分子囊泡——一种有前景的干细胞疗法平台, objectType=article, longId=138506, objectId=ff0013850689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0013850689, replyNumber=0, likeNumber=0, createdTime=2018-06-04, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0013850689, moduleTitle=ACS Appl Mater Interfaces：超分子囊泡——一种有前景的干细胞疗法平台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0013850689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080912, encodeId=a0c0208091275, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=医疗领域最有前景的10大AI应用，这些你知道吗？, objectType=article, longId=140518, objectId=47ca140518c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47ca140518c1, replyNumber=0, likeNumber=34, createdTime=2018-07-30, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47ca140518c1, moduleTitle=医疗领域最有前景的10大AI应用，这些你知道吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47ca140518c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080913, encodeId=c31a20809139c, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=医疗领域最有前景的AI应用价值达1500亿美元, objectType=article, longId=140620, objectId=1a3c1406209e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a3c1406209e, replyNumber=0, likeNumber=47, createdTime=2018-09-06, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a3c1406209e, moduleTitle=医疗领域最有前景的AI应用价值达1500亿美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a3c1406209e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080910, encodeId=f7dd2080910d5, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=Diabetologia：一种有前景的2型糖尿病治疗方法？, objectType=article, longId=135131, objectId=4eec135131b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eec135131b6, replyNumber=0, likeNumber=36, createdTime=2018-12-31, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eec135131b6, moduleTitle=Diabetologia：一种有前景的2型糖尿病治疗方法？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eec135131b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080908, encodeId=79be2080908a4, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=有前景的新型癌症疫苗, objectType=article, longId=107452, objectId=3eab10e452dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eab10e452dd, replyNumber=0, likeNumber=39, createdTime=2017-09-06, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eab10e452dd, moduleTitle=有前景的新型癌症疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eab10e452dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080909, encodeId=a87c208090991, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=Int J Biol Macromol：组织工程又一有前景的支架材料, objectType=article, longId=122322, objectId=1581122322ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1581122322ba, replyNumber=0, likeNumber=29, createdTime=2018-03-01, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1581122322ba, moduleTitle=Int J Biol Macromol：组织工程又一有前景的支架材料, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1581122322ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2080907, encodeId=b5a2208090e59, content=<a href='/topic/show?id=6d0260588eb' target=_blank style='color:#2F92EE;'>#有前景#</a>, objectTitle=Cancer Cell：区分肾癌亚型有前景的新药靶点, objectType=article, longId=3640, objectId=b9573640ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9573640ac, replyNumber=0, likeNumber=40, createdTime=2012-11-02, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9573640ac, moduleTitle=Cancer Cell：区分肾癌亚型有前景的新药靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9573640ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

有前景

2020-05-29

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

ESMO 2022：Sacituzumab Govitecan-hziy在HER2-低表达/HER2-0转移性乳腺癌中显示出有前景的疗效（TROPiCS-02研究）

2023-05-23

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

BMC Cancer：白蛋白紫杉醇联合PD-1抑制剂信迪利单抗是晚期软组织肉瘤(STS)的有前景治疗方案

2022-12-08

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

Stroke：中性粒细胞计数作为预测动脉瘤性蛛网膜下腔出血患者住院死亡率有前景的标志物

2021-10-22

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

Medicine：乌司他丁联合中药大黄可能是改善败血症的一种有前景的治疗方案

2022-01-21

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

Clinica Chimica Acta：血清脂蛋白相关磷脂酶A2是一种有前景预后生物标志物，与急性脑出血90天的预后有关

2020-02-01

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

石榴中的抗衰老化合物在人类临床试验中被证明有前景

2019-10-22

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

Sci Rep：一个很有前景的前列腺癌预测工具PI-RADS V2介绍

2019-09-28

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

BMS的PD-1单抗联合CTLA-4单抗治疗肝细胞癌的早期临床结果很有前景

2020-04-27

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

ACS Appl Mater Interfaces：超分子囊泡——一种有前景的干细胞疗法平台

2018-06-04

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

医疗领域最有前景的10大AI应用，这些你知道吗？

2018-07-30

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

医疗领域最有前景的AI应用价值达1500亿美元

2018-09-06

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

Diabetologia：一种有前景的2型糖尿病治疗方法？

2018-12-31

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

有前景的新型癌症疫苗

2017-09-06

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

Int J Biol Macromol：组织工程又一有前景的支架材料

2018-03-01

jjjiang0199 (审核中...)

前往app查看评论内容

#有前景#

Cancer Cell：区分肾癌亚型有前景的新药靶点

2012-11-02

科室
- - 订阅+
  - 更多科室
工具
服务